THE SIGNIFICANT EFFECT OF HLA-DRB1 MATCHING ON LONG-TERM KIDNEY GRAFT OUTCOME

被引:16
作者
ICHIKAWA, Y
HASHIMOTO, M
NOJIMA, M
SATA, M
FUJIMOTO, N
KYO, M
ISHIBASHI, M
OHSHIMA, S
AMEMIYA, H
FUKUNISHI, T
NAGANO, S
SONODA, T
机构
[1] HYOGO PREFECTURAL NISHINOMIYA HOSP,CTR KIDNEY TRANSPLANT,NISHINOMIYA,HYOGO 662,JAPAN
[2] HYOGO MED COLL,DEPT UROL,NISHINOMIYA,HYOGO 663,JAPAN
[3] NATL CARDIOVASC CTR,RES INST,DEPT SURG RES,SUITA,OSAKA 565,JAPAN
[4] OSAKA UNIV HOSP,DEPT UROL,OSAKA,OSAKA 553,JAPAN
[5] SOCIAL INSURANCE CHUKYO HOSP,DEPT UROL,NAGOYA,AICHI 457,JAPAN
[6] OSAKA PREFECTURAL GEN HOSP,OSAKA,OSAKA 558,JAPAN
关键词
D O I
10.1097/00007890-199312000-00017
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Serotyping and genotyping (polymerase chain reaction with sequence-specific oligonucleotide probes method) were conducted on 520 unrelated individuals to determine the linkage disequilibrium of HLA-B and HLA-DRB1. Analyses of 511 kidney transplants (300 related and 211 cadaver recipients) were carried out at 4 transplant centers using the linkage disequilibrium of HLA-B and HLA-DRB1 established previously. All transplant recipients received CsA immunosuppression and were transplanted from June 1983 to December 1991. There were 51 significant linkages formed between HLA-B and HLA-DRB1 alleles (P<0.05). DRB1-compatible transplants experienced a comparable 5-year graft success rate of 94% as did the HLA-identical recipients with a 100% B-year success rate. However DRB1-incompatible recipients displayed a significantly reduced 5-year graft survival rate of 73% (73% vs. 94% P<0.01). The 5-year graft survival rate of HLA-DR-incompatible recipients of 71% was compatible to the 73% for HLA-DRB1-incompatible recipients. No variation of rejection rate for DRB1-compatible grafts was seen in any of the 4 transplant centers. The results also indicated that HLA-DRB1 compatibility was essential for optimal success rate, regardless of HLA class I mismatches. The overall conclusion was that matching for HLA-DR was important to achieve optimal kidney graft survival on the molecular level but not on the serotyping level.
引用
收藏
页码:1368 / 1371
页数:4
相关论文
共 29 条
[21]  
OPELZ G, 1991, LANCET, V338, P462
[22]  
RINGDEN O, 1977, TISSUE ANTIGENS, V10, P364
[23]   HLA-DPB1 ALLELE MISMATCHES BETWEEN UNRELATED HLA-A,B,C,DR (GENERIC) DQA1-IDENTICAL UNRELATED INDIVIDUALS WITH UNREACTIVE MLC [J].
SALAZAR, M ;
YUNIS, I ;
ALOSCO, SM ;
CHOPEK, M ;
YUNIS, EJ .
TISSUE ANTIGENS, 1992, 39 (04) :203-208
[24]   PRIMARY MIXED LYMPHOCYTE-RESPONSES TO HLA-DP [J].
SELL, TW ;
ECKELS, DD .
HUMAN IMMUNOLOGY, 1990, 29 (01) :23-30
[25]   OLIGONUCLEOTIDE TYPING IS A PERFECT TOOL TO IDENTIFY ANTIGENS STIMULATORY IN THE MIXED LYMPHOCYTE CULTURE [J].
TERMIJTELEN, A ;
ERLICH, HA ;
BRAUN, LA ;
VERDUYN, W ;
DRABBELS, JJM ;
SCHROEIJERS, WEM ;
VANROOD, JJ ;
DEKOSTER, HS ;
GIPHART, MJ .
HUMAN IMMUNOLOGY, 1991, 31 (04) :241-245
[26]   SELECTION OF UNRELATED DONORS FOR BONE-MARROW TRANSPLANTATION IS IMPROVED BY HLA CLASS-II GENOTYPING WITH OLIGONUCLEOTIDE HYBRIDIZATION [J].
TIERCY, JM ;
MOREL, C ;
FREIDEL, AC ;
ZWAHLEN, F ;
GEBUHRER, L ;
BETUEL, H ;
JEANNET, M ;
MACH, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (16) :7121-7125
[27]   APPLICATION OF HLA-DR OLIGOTYPING TO 110 KIDNEY-TRANSPLANT PATIENTS WITH DOUBTFUL SEROLOGICAL TYPING [J].
TIERCY, JM ;
GOUMAZ, C ;
MACH, B ;
JEANNET, M .
TRANSPLANTATION, 1991, 51 (05) :1110-1114
[28]  
TING A, 1984, KIDNEY TRANSPLANTATI, P159
[29]  
WALKER J, 1978, TRANSPLANT P, V10, P949